Results 261 to 270 of about 93,702 (291)

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Lancet, The, 2011
Colin Baigent, Martin J Landray, Jonathan R Emberson   +2 more
exaly  

Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?

Lancet, The, 1997
Stefan Sjöberg
exaly  

Simvastatin

Reactions Weekly
  +4 more sources

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)

Lancet, The, 2004
Timo E Strandberg, Gudmundur Thorgeirsson, John Kjekshus   +2 more
exaly  

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2014
Nadine Schuerer, David MacManus, Charles R M Bangham   +2 more
exaly  

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

Lancet, The, 2004
Inderjit Singh
exaly  

Simvastatin

Reactions Weekly, 1991
openaire   +2 more sources

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

Lancet, The, 2010
Jane Armitage, Frcp, Louise Bowman, Karl Wallendszus   +2 more
exaly  

Simvastatin

Reactions Weekly, 2006
openaire   +1 more source

Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia

Lancet, The, 1997
Domenico Ferro, Stefania Basili, Francesco Violi   +2 more
exaly